Skip to main content
Top
Published in: Lung 5/2013

01-10-2013

Giant Bullae Emphysema

Authors: Christian Ghattas, Timothy J. Barreiro, David J. Gemmel

Published in: Lung | Issue 5/2013

Login to get access

Abstract

Bullous lung disease, a variant of the emphysematous process, can come in different forms and presentations, both histologically and radiographically. Giant bulla (GB) is the rarest form of bullous lung disease. Onset of disease to duration to symptoms is unclear. Presenting symptoms include cough, chest pain, and progressive dyspnea. Differentiating between other cystic lung diseases or developmental/congenital anomalies is vital. While most patients with bullous lung disease can be managed medically, those with giant bulla should be referred for careful surgical evaluation. The authors describe GB, highlight the role of imaging, and discuss the evaluation and pathophysiology of this rare presentation.
Literature
3.
go back to reference Morgan MD, Edwards CW, Morris J, Matthews HR (1989) Origin and behaviour of emphysematous bullae. Thorax 44(7):533–538PubMedCrossRef Morgan MD, Edwards CW, Morris J, Matthews HR (1989) Origin and behaviour of emphysematous bullae. Thorax 44(7):533–538PubMedCrossRef
Metadata
Title
Giant Bullae Emphysema
Authors
Christian Ghattas
Timothy J. Barreiro
David J. Gemmel
Publication date
01-10-2013
Publisher
Springer US
Published in
Lung / Issue 5/2013
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-013-9495-z

Other articles of this Issue 5/2013

Lung 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine